Creighton University is a private, Jesuit university in Omaha, Nebraska. Founded by the Society of Jesus in 1878, the university is accredited by the Higher Learning Commission.

During the past decade, Creighton University conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 22 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Creighton University" #1 sponsor was "Creighton University" with 50 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Abbott Nutrition" with 2 trials sponsored and "Columbia University" with 2 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Creighton University" #1 collaborator was "Creighton University" with 3 trials as a collaborator, "Dialysis Clinic, Inc." with 3 trials as a collaborator, "University of Nebraska" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Creighton University" are "Osteoporosis" (6 trials), "Vitamin D Deficiency" (6 trials), "Maternal-Fetal Relations" (4 trials), "Asthma" (3 trials) and "Chronic Kidney Disease" (3 trials). Many other conditions were trialed in "Creighton University" in a lesser frequency.

Most popular intervention types in "Creighton University" are "Drug" (39 trials), "Other" (22 trials), "Behavioral" (13 trials), "Biological" (6 trials) and "Dietary Supplement" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "3D printed model" (4 trials), "cholecalciferol" (4 trials), "Nintedanib" (3 trials) and "Risperidone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Creighton University" are 83 trials for "All" genders, 14 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Creighton University". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in Creighton University, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Creighton University, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 31 trials that are defined as “Not Applicable".

Creighton University has several departments that took part in Clinical trials: "The Cardiac Center at Creighton University" - 17 trials, "Creighton University Department of Psychiatry" - 13 trials, "Creighton University School of Dentistry" - 6 trials, "Cancer Center at Creighton University Medical Center" - 5 trials, "Creighton Nephrology" - 2 trials, "Creighton University/Department of Neurology" - 2 trials, "Creighton University Division of Allergy & Immunology" - 2 trials